Skip to content

Randomised open controlled clinical study to assess the add on effect 0f siravedhan in the management of grudhrasi w.s.r to sciatica

Randomised open controlled clinical study to assess the add on effect of siravedhan in the management of grudhrasi w.s.r to sciatica - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073081
Enrollment
80
Registered
2024-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Prajakta Vishnu Bhise
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinical sign and symptoms gridhrasi w.s.r to sciatica 2. Positive SLR test 3. Age group of 25-60 years. 4. Both the gender patients. 5. Patient is fit for siravedhan

Exclusion criteria

Exclusion criteria: 1.Patients with severe Systemic disorder. 2. Pregnant and lactative mother.

Design outcomes

Primary

MeasureTime frame
Assessment of reduced sign and symptoms like Spandan,Ruk,Tod,Gaurav and StambhaTimepoint: 4 weeks

Secondary

MeasureTime frame
To study the add on effect of siravedhan karma. To compare the both therapies. To assess improvement by signs symptoms and gradation of assessement criteria.Timepoint: 7 days

Countries

India

Contacts

Public ContactDR PRAJAKTA VISHNU BHISE

Yashwant Ayurvedic College Post Graduate Training And Research Centre kodoli

drabhijeetingavale@gmaim.com9822919000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026